S. Goldring and E. Gravallese, Mechanisms of bone loss in inflammatory arthritis: diagnosis and therapeutic implications, Arthritis Research, vol.2, issue.1, pp.33-37, 2000.
DOI : 10.1186/ar67

C. Confavreux and R. Chapurlat, Systemic bone effects of biologic therapies in rheumatoid arthritis and ankylosing spondylitis, Osteoporosis International, vol.1192, issue.Suppl 3, pp.1023-1036, 2011.
DOI : 10.1007/s00198-010-1462-4

H. Reichel, H. Koeffer, R. Barbers, and A. Norman, Production by Cultured Alveolar Macrophages from Normal Human Donors and from Patients with Pulmonary Sarcoidosis*, The Journal of Clinical Endocrinology & Metabolism, vol.65, issue.6, pp.1201-1209, 1987.
DOI : 10.1210/jcem-65-6-1201

G. Rizzato, Clinical impact of bone and calcium metabolism changes in sarcoidosis, Thorax, vol.53, issue.5, pp.425-429, 1998.
DOI : 10.1136/thx.53.5.425

P. Stern, D. Olazabal, J. Bell, and N. , Evidence for abnormal regulation of circulating 1 alpha,25-dihydroxyvitamin D in patients with sarcoidosis and normal calcium metabolism., Journal of Clinical Investigation, vol.66, issue.4, pp.852-855, 1980.
DOI : 10.1172/JCI109924

G. Rizzato and L. Montemurro, Reversibility of exogenous corticosteroid-induced bone loss, Eur Respir J, vol.6, pp.116-119, 1993.

G. Rizzato and P. Fraioli, Natural and corticosteroid-induced osteoporosis in sarcoidosis: prevention, treatment, follow up and reversibility, pp.89-92, 1990.

G. Rizzato, G. Tosi, C. Mella, L. Montemurro, D. Zanni et al., Prednisone-induced bone loss in sarcoidosis: a risk especially frequent in postmenopausal women, Sarcoidosis, vol.5, pp.93-98, 1988.

S. Sipah, S. Tuzun, R. Ozaras, H. Calis, N. Ozaras et al., Bone mineral density in women with sarcoidosis, J Bone Miner Metab, vol.22, pp.48-52, 2004.

R. Adler, H. Funkhouser, V. Petkov, and M. Berger, Glucocorticoid-Induced Osteoporosis in Patients with Sarcoidosis, The American Journal of the Medical Sciences, vol.325, issue.1, pp.1-6, 2003.
DOI : 10.1097/00000441-200301000-00001

L. Montemurro, P. Fraioli, A. Riboldi, S. Delpiano, D. Zanni et al., Bone loss in prednisone treated sarcoidosis: a two-year follow-up, Ann Ital Med Int, vol.5, pp.164-168, 1990.

G. Rizzato, G. Tosi, C. Mella, D. Zanni, S. Sisti et al., Researching osteoporosis in prednisone treated sarcoid patients, Sarcoidosis, vol.4, pp.45-48, 1987.

A. Heijckmann, M. Drent, B. Dumitrescu, D. Vries, J. et al., Progressive vertebral deformities despite unchanged bone mineral density in patients with sarcoidosis: a 4-year follow-up study, Osteoporosis International, vol.15, issue.6, pp.839-847, 2008.
DOI : 10.1016/8756-3282(94)90822-2

P. Fardellone, J. Sebert, M. Bouraya, O. Bonidan, G. Leclercq et al., Evaluation of the calcium content of diet by frequential self-questionnaire, Rev Rhum Mal Osteoartic, vol.58, pp.99-103, 1991.

H. Genant, C. Wu, C. Van-kuijk, and M. Nevitt, Vertebral fracture assessment using a semiquantitative technique, Journal of Bone and Mineral Research, vol.13, issue.S1, pp.1137-1148, 1993.
DOI : 10.1002/jbmr.5650080915

A. Ross, J. Manson, S. Abrams, J. Aloia, P. Brannon et al., The 2011 Report on Dietary Reference Intakes for Calcium and Vitamin D from the Institute of Medicine: What Clinicians Need to Know, The Journal of Clinical Endocrinology & Metabolism, vol.96, issue.1, pp.53-58, 2011.
DOI : 10.1210/jc.2010-2704

D. Kavathia, J. Buckley, D. Rao, B. Rybicki, and R. Burke, Elevated 1, 25-dihydroxyvitamin D levels are associated with protracted treatment in sarcoidosis, Respiratory Medicine, vol.104, issue.4, pp.564-570, 2010.
DOI : 10.1016/j.rmed.2009.12.004

K. Sanders, A. Stuart, E. Williamson, J. Simpson, M. Kotowicz et al., Annual High-Dose Oral Vitamin D and Falls and Fractures in Older Women, JAMA, vol.303, issue.18, pp.815-822, 2010.
DOI : 10.1001/jama.2010.594

G. Grimnes, R. Joakimsen, Y. Figenschau, P. Torjesen, B. Almås et al., The effect of high-dose vitamin D on bone mineral density and bone turnover markers in postmenopausal women with low bone mass???a randomized controlled 1-year trial, Osteoporosis International, vol.303, issue.1, pp.201-211, 2012.
DOI : 10.1007/s00198-011-1752-5

K. Ensrud, S. Ewing, L. Fredman, M. Hochberg, J. Cauley et al., Circulating 25-Hydroxyvitamin D Levels and Frailty Status in Older Women, The Journal of Clinical Endocrinology & Metabolism, vol.95, issue.12, pp.5266-5273, 2010.
DOI : 10.1210/jc.2010-2317

B. Dawson-hughes and S. Harris, High-Dose Vitamin D Supplementation, JAMA, vol.303, issue.18, pp.1861-1862, 2010.
DOI : 10.1001/jama.2010.598

Y. Ueno, T. Shinki, Y. Nagai, H. Murayama, K. Fujii et al., In vivo administration of 1,25-dihydroxyvitamin D3 suppresses the expression of RANKL mRNA in bone of thyroparathyroidectomized rats constantly infused with PTH, Journal of Cellular Biochemistry, vol.8, issue.2, pp.267-277, 2003.
DOI : 10.1002/jcb.10623

P. Anderson, S. Iida, J. Tyson, A. Turner, and H. Morris, Bone CYP27B1 gene expression is increased with high dietary calcium and in mineralising osteoblasts, The Journal of Steroid Biochemistry and Molecular Biology, vol.121, issue.1-2, pp.71-75, 2010.
DOI : 10.1016/j.jsbmb.2010.03.021

K. Hamada, S. Nagai, T. Tsutsumi, and T. Izumi, Bone mineral density and vitamin D in patients with sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis, pp.219-223, 1999.

P. Lips, Relative Value of 25(OH)D and 1,25(OH)2D Measurements, Journal of Bone and Mineral Research, vol.145, issue.90, pp.1668-1671, 2007.
DOI : 10.1359/jbmr.070716

P. Welsh, M. Peters, I. Mcinnes, W. Lems, P. Lips et al., Vitamin D deficiency is common in patients with RA and linked to disease activity, but circulating levels are unaffected by TNF?? blockade: results from a prospective cohort study, Annals of the Rheumatic Diseases, vol.70, issue.6, pp.1165-1167, 2011.
DOI : 10.1136/ard.2010.137265

B. Bouvard, C. Annweiler, A. Sallé, O. Beauchet, D. Chappard et al., Extraskeletal effects of vitamin??D: Facts, uncertainties, and controversies, Joint Bone Spine, vol.78, issue.1, pp.10-16, 2011.
DOI : 10.1016/j.jbspin.2010.10.011

R. Baughman, J. Janovcik, M. Ray, N. Sweiss, and E. Lower, Calcium and vitamin D metabolism in sarcoidosis, Sarcoidosis Vasc Diffuse Lung Dis, vol.1, pp.113-120, 2013.

M. Van-der-klift, C. De-laet, E. Mccloskey, A. Hofman, and H. Pols, The Incidence of Vertebral Fractures in Men and Women: The Rotterdam Study, Journal of Bone and Mineral Research, vol.10, issue.6, pp.1051-1056, 2002.
DOI : 10.1359/jbmr.2002.17.6.1051

J. Siffledeen, K. Siminoski, H. Jen, and R. Fedorak, Vertebral Fractures and Role of Low Bone Mineral Density in Crohn???s Disease, Clinical Gastroenterology and Hepatology, vol.5, issue.6, pp.721-728, 2007.
DOI : 10.1016/j.cgh.2007.02.024

A. Heijckmann, M. Huijberts, D. Vries, J. Menheere, P. Van-der et al., Bone turnover and hip bone mineral density in patient with sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis, pp.51-58, 2007.